CMS Finalizes Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease Decision Follows Robust Stakeholder Input and Creates Pathway
CMS Returning to Certain Pre-COVID-19 Policies in Long-term Care and Other Facilities Actions continue to protect the health and safety of nursing home residents The
As of April 5, 2022, the U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for GSK-Vir Biotechnology’s sotrovimab monoclonal antibody treatment.
“Moral injury has been defined as the “psychological, biological, spiritual, behavioral and social impact of perpetrating, failing to prevent, or bearing witness to acts that
What is already known about this topic? Currently, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are recommended for
Linda Spaulding featured on the Health Watch USA YouTube channel and discusses COVID-19 in the state of Florida.
FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19,
Don’t risk taking body fluids, bacteria or viruses home anymore. VESTEX is the company to go to. They are approved by the FDA and work